Innovation Improves Laboratory Productivity Across Sample Handling, Analysis, Storage and Protection
ATLANTA (July 26, 2011) - Thermo Fisher Scientific Inc. (NYSE:TMO), the
world leader in serving science, today introduced a comprehensive range of
clinical research and diagnostic products at the annual conference of the
American Association for Clinical Chemistry (AACC). From automated sample
handling to innovative sample analysis and storage solutions, ThermoFisher
provides an integrated approach to accelerating results in the clinical
laboratory. Visit Booth #1720 during Clinical Lab Expo at the AACC
conference being held at the Georgia World Congress Center, Atlanta,
Georgia, from July 26-28.
"We are committed to developing products and solutions that simplify the
clinical chemistry workflow and allow our customers to focus their attention
on patients," said Marc N. Casper, president and chief executive officer of
Thermo Fisher Scientific. "Our novel biomarkers, for example, used to
diagnose life-threatening illnesses, enable our customers to improve patient
outcomes and reduce the length of associated hospital stays. The AACC
conference provides us with the opportunity to showcase our depth of
capabilities in clinical diagnostics and hear directly from our customers
about their goals for improving patient care."
Advances in drugs-of-abuse testing and therapeutic drug monitoring
This year at AACC, the company will introduce the Thermo Scientific Indiko,
a fully automated, compact chemistry analyzer. The Indiko recently received
clearance from the U.S. Food and Drug Administration (FDA) and is designed
for routine clinical chemistry applications, including drugs-of-abuse
testing and therapeutic drug monitoring. The system employs Thermo
Scientific bar-coded reagents to simplify operation and allow flexibility in
the use of the equipment.
Also at AACC is the Thermo Scientific QMS
Everolimus Reagent kit which recently received FDA clearance for use on an
automated clinical analyzer to monitor levels of anti-rejection medication
in the blood of kidney transplant patients.
In the rapidly evolving market for drugs-of-abuse testing, the company's six
new Thermo Scientific Oral Fluid immunoassays provide a dramatic improvement
in convenience over conventional methods. These FDA-cleared assays are used
to test for amphetamines, cannabinoids (THC), cocaine, methamphetamines,
opiates and PCP.
Improved productivity in clinical research applications
Thermo Fisher will also highlight an improved liquid chromatography/mass
spectrometry (LC/MS)workflow for immunosuppressant analysis designed to
improve productivity in clinical research applications. Within this
workflow, the Thermo Scientific Versette automated liquid-handling platform
is used to simplify the sample-handling method, whether the research chemist
is transitioning from handheld pipetting or establishing an integrated
system. This workflow also incorporates the latest release of Thermo
Scientific TraceFinder 1.1 software, designed for use in clinical research
and forensic toxicology testing.
TraceFinder software has been specifically adapted for use on the Thermo
Scientific Transcend system known for its Turbo-Flow technology and
multiplexing capability. Multiplexing allows up to four independent HPLC
channels to connect to a single mass spectrometer, reducing cost and
increasing clinical research laboratory flexibility and productivity.
Innovative solutions for sample protection and storage
The Thermo Scientific Revco UxF Series ultra-low temperature freezer, also
new at AACC, provides sample protection in a variety of capacities while
maintaining high standards for energy efficiency and space utilization. In
addition, the new Thermo Scientific AssayAssure sample preservation kits
ensure sample integrity without refrigeration.
For more information on the comprehensive range of Thermo Scientific
clinical research and diagnostic products, please visit booth #1720 during
AACC 2011 or visit the online media room at
http://www.thermofisher.com/AACC2011http://www.thermofisher.com/AACC2011
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving
science. Our mission is to enable our customers to make the world healthier,
cleaner and safer. With revenues of nearly $11 billion, we have
approximately 37,000 employees and serve customers within pharmaceutical and
biotech companies, hospitals and clinical diagnostic labs, universities,
research institutions and government agencies, as well as in environmental
and process control industries. We create value for our key stakeholders
through two premier brands, Thermo Scientific and Fisher Scientific, which
offer a unique combination of continuous technology development and the most
convenient purchasing options. Our products and services help accelerate the
pace of scientific discovery, and solve analytical challenges ranging from
complex research to routine testing to field applications. Visit www.thermofisher.com.
Media Contact Information:
Ron O'Brien
Phone: 781-622-1242
E-mail: [email protected]
Website: www.thermofisher.com
Investor Contact Information:
Ken Apicerno
Phone: 781-622-1294
E-mail: [email protected]